Highly Stereoselective Syntheses of Proline-Derived Vicinal Amino Alcohols through Grignard Addition onto N-Tosylprolinal

Saikat Chaudhuri; Amarchand Parida; Santanu Ghosh; Alakesh Bisai

doi:10.1055/s-0035-1560802

Synlett, Inhaltsverzeichnis

Synlett 2016; 27(02): 215-220
DOI: 10.1055/s-0035-1560802

letter

Highly Stereoselective Syntheses of Proline-Derived Vicinal Amino Alcohols through Grignard Addition onto N-Tosylprolinal

Saikat Chaudhuri

Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal Bypass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India eMail: alakesh@iiserb.ac.in

,

Amarchand Parida

Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal Bypass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India eMail: alakesh@iiserb.ac.in

,

Santanu Ghosh

Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal Bypass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India eMail: alakesh@iiserb.ac.in

,

Alakesh Bisai*

Department of Chemistry, Indian Institute of Science Education and Research Bhopal, Bhopal Bypass Road, Bhauri, Bhopal 462 066, Madhya Pradesh, India eMail: alakesh@iiserb.ac.in

› Institutsangaben

Abstract

Alle Artikel dieser Rubrik

Abstract

A highly diastereoselective Grignard addition to N-tosyl-l-prolinal has been developed to deliver a variety of proline-derived vicinal amino alcohols in good to excellent yields with high diastereoselectivities. A similar selectivity was also obtained by using N-tosyl-d-prolinal. The methodology has been applied to the synthesis of medicinally important 3-hydroxy-2-phenylpiperidines.

Key words

prolinol - Grignard addition - diastereoselectivity - aziridinium ion - natural products

Volltext

Referenzen

References and Notes

1a Halskov KS, Kniep F, Lauridsen VH, Iversen EH, Donslund BS, Jørgensen KA. J. Am. Chem. Soc. 2015; 137: 1685
1b Franzén J, Marigo M, Fielenbach D, Wabnitz TC, Kjærsgaard A, Jørgensen KA. J. Am. Chem. Soc. 2005; 127: 18296

2a Corey EJ, Bakshi RK, Shibata S. J. Am. Chem. Soc. 1987; 109: 5551
2b Trost BM, Shin S, Sclafani JA. J. Am. Chem. Soc. 2005; 127: 8602
2c Trost BM, Bartlett MJ. Acc. Chem. Res. 2015; 48: 688 ; and references therein

For the isolation of dolastatin 10, see:

3a Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH. J. Nat. Prod. 2001; 64: 907
3b Salvador-Reyes LA, Engene N, Paul VJ, Luesch H. J. Nat. Prod. 2015; 78: 486

4 For the isolation of symplostatin 1, see: Harrigan GG, Luesch H, Yoshida WY, Moore RE, Nagle DG, Paul VJ, Mooberry SL, Corbett TH, Valeriote FA. J. Nat. Prod. 1998; 61: 1075
5 For the isolation of malevamide D, see: Horgen FD, Kazmierski EB, Westenburg HE, Yoshida WY, Scheuer PJ. J. Nat. Prod. 2002; 65: 487
6 For auristatins, see: Pettit GR, Hogan F, Toms S. J. Nat. Prod. 2011; 74: 962
7 Maderna A, Doroski M, Subramanyam C, Porte A, Leverett CA, Vetelino BC, Chen Z, Risley H, Parris K, Pandit J, Varghese AH, Shanker S, Song C, Sukura SC. K, Farley KA, Wagenaar MM, Shapiro MJ, Musto S, Lam M.-H, Loganzo F, O’Donnell CJ. J. Med. Chem. 2014; 57: 10527

8a Pettit GR, Anderson CR, Gapud EJ, Jung MK, Knight JC, Hamel E, Pettit RK. J. Nat. Prod. 2005; 68: 1191
8b For a review, see: Maderna A, Leverett CA. Mol. Pharmaceutics 2015; 12: 1798

9 For the synthesis of 1a, see: Reed PE, Katzenellenbogen JA. J. Org. Chem. 1991; 56: 2624
10 León B, Fong JC. N, Peach KC, Wong WR, Yildiz FH, Linington RG. Org. Lett. 2013; 15: 1234

11a Roche C, Delair P, Greene AE. Org. Lett. 2003; 5: 1741
11b Snider BB, Gao X. Org. Lett. 2005; 7: 4419
11c Vargas-Sanchez M, Couty F, Evano G, Prim D, Marrot J. Org. Lett. 2005; 7: 5861
11d El-Naggar M, Piggott AM, Capon RJ. Org. Lett. 2008; 10: 4247
11e Zhang H, Zhang C.-R, Zhu K.-K, Gao A.-H, Luo C, Li J, Yue J.-M. Org. Lett. 2013; 15: 120

12 For tylophoridicine E, see: Stoye A, Peez TE, Opatz T. J. Nat. Prod. 2013; 76: 275 ; and references cited

13a Liu L.-X, Ruan Y.-P, Guo Z.-Q, Huang P.-Q. J. Org. Chem. 2004; 69: 6001
13b Tsai M.-R, Chen B.-F, Cheng C.-C, Chang N.-C. J. Org. Chem. 2005; 70: 1780

14 For (+)-GR-205,171 (5b), see: Fabio RD, Griffante C, Alvaro G, Pentassuglia G, Pizzi DA, Donati D, Rossi T, Guercio G, Mattioli M, Cimarosti Z, Marchioro C, Provera S, Zonzini L, Montanari D, Melotto S, Gerrard PA, Trist DG, Ratti E, Corsi M. J. Med. Chem. 2009; 52: 3238
15 Clavez O, Langlois N. Tetrahedron Lett. 1999; 40: 7099

For 3-hydroxypipecolinic acid, see:

16a Kumar P, Bodas MS. J. Org. Chem. 2005; 70: 360
16b Liang N, Datta A. J. Org. Chem. 2005; 70: 10182
16c Kalamkar NB, Kasture VM, Dhavale DD. J. Org. Chem. 2008; 73: 3619
16d Chiou W.-H, Lin G.-H, Liang C.-W. J. Org. Chem. 2010; 75: 1748
16e Kokatla HP, Lahiri R, Kancharla PK, Doddi VR, Vankar YD. J. Org. Chem. 2010; 75: 4608

17a Wipf P, Hopkins CR. J. Org. Chem. 2001; 66: 3133
17b Scott JD, Williams RM. J. Am. Chem. Soc. 2002; 124: 2951
17c Wu Y.-C, Liron M, Zhu J. J. Am. Chem. Soc. 2008; 130: 7148

18a Lemire A, Grenon M, Pourashraf M, Charette AB. Org. Lett. 2004; 6: 3517
18b Kise N, Ohya K, Arimoto K, Yamashita Y, Hirano Y, Ono T, Ueda N. J. Org. Chem. 2004; 69: 7710
18c Liu R.-H, Fang K, Wang B, Xu M.-H, Lin G.-Q. J. Org. Chem. 2008; 73: 3307
18d Huy PH, Koskinen AM. P. Org. Lett. 2013; 15: 5178

19a Lee J, Hoang T, Lewis S, Weissman SA, Askin D, Volante RP, Reider PJ. Tetrahedron Lett. 2001; 42: 6223
19b Cossy J, Dumas C, Pardo DG. Eur. J. Org. Chem. 1999; 1693
19c Métro T.-X, Appenzeller J, Pardo DG, Cossy J. Org. Lett. 2006; 8: 3509
19d Cochi A, Burger B, Navarro C, Pardo DG, Cossy J, Zhao Y, Cohen T. Synlett 2009; 2157
19e Cochi A, Pardo DG, Cossy J. Org. Lett. 2011; 13: 4442
19f Rioton S, Orliac A, Antoun Z, Bidault R, Pardo DG, Cossy J. Org. Lett. 2015; 17: 2916
19g Bilke JL, Moore SP, O’Brien P, Gilday J. Org. Lett. 2009; 11: 1935

20a Andrés JM, Pedrosa R, Pérez A, Pérez-Encabo A. Tetrahedron 2001; 57: 8521
20b Ma D, Pan Q, Han F. Tetrahedron Lett. 2002; 43: 9401

21a Harris BD, Bhat KL, Joullié MM. Heterocycles 1986; 24: 1045
21b Reed PE, Katzenellenbogen JA. J. Org. Chem. 1991; 56: 2624
21c Ito H, Ikeuchi Y, Taguchi T, Hanzawa Y. J. Am. Chem. Soc. 1994; 116: 5469
21d Mahboobi S, Popp A, Burgemeister T, Schollmeyer D. Tetrahedron: Asymmetry 1998; 9: 2369 ; and references cited therein

22a Barrett AG. M, Damiani F. J. Org. Chem. 1999; 64: 1410
22b Konradi AW, Kemp SJ, Pedersen SF. J. Am. Chem. Soc. 1994; 116: 1316

23a Soai K, Ookawa A. J. Chem. Soc., Chem. Commun. 1986; 412
23b Soai K, Ookawa A, Kaba T, Ogawa K. J. Am. Chem. Soc. 1987; 109: 7111
23c Klein G, Pandiaraju S, Reiser O. Tetrahedron Lett. 2002; 43: 7503

24a Funabiki K, Shibata A, Iwata H, Hatano K, Kubota Y, Komura K, Ebihara M, Matsui M. J. Org. Chem. 2008; 73: 4694
24b Marquez F, Montoro R, Llebaria A, Lago E, Molins E, Delgado A. J. Org. Chem. 2002; 67: 308
24c Pettit GR, Grealish MP. J. Org. Chem. 2001; 66: 8640
24d Pettit GR, Singh SB, Herald DL, Lloyd-Williams P, Kantoci D, Burkett DD, Barkóczy J, Hogan F, Wardlaw TR. J. Org. Chem. 1994; 59: 6287
24e Soai K, Ookawa A, Kaba T, Ogawa K. J. Am. Chem. Soc. 1987; 109: 7111
24f Soai K, Ookawa A. Chem. Commun. 1986; 412

25a Bejjani J, Chemla F, Audouin M. J. Org. Chem. 2003; 68: 9747
25b For use of 9e in total synthesis, see: Liu P, Hong S, Weinreb SM. J. Am. Chem. Soc. 2008; 130: 7562

26 MeMgBr addition to 4-(S)-TBS-protected-N-tosyl-d-prolinal afforded the products in 1.32:1 dr, see: Remuzon P, Bouzard D, Guiol C, Jacquet J.-P. J. Med. Chem. 1992; 35: 2898
27 The diastereoselectivities in case of allylmagnesium halide addition to N-trityl-l-prolinal (9e) afforded the products with <2:1 dr [see ref. 25a].
28 Addition of Grignard Reagents to the Aldehyde; General Procedure: To a stirred solution of crude 10 (253 mg, 1.0 mmol, 1.0 equiv) in anhydrous THF at –78 °C was added RMgBr (1.3 mmol, 1.3 equiv) slowly over a period of 5 min, and stirring was continued for 4 h. The reaction was quenched with sat. aq NH₄Cl (2 mL) and extracted with EtOAc (3 × 20 mL). The combined organic layers were dried over anhydrous sodium sulfate and concentrated under reduced pressure. The crude mixture was purified by column chromatography to afford the desired product 15.( R )-Phenyl [(S)-1-Tosylpyrrolidin-2-yl] methanol [(–)-15a)]: White crystalline solid; R_f 0.51 (EtOAc–hexane, 20%). ¹H NMR (400 MHz, CDCl₃): δ = 7.74 (d, J = 8.25 Hz, 2 H), 7.38 (m, 2 H), 7.29–7.32 (m, 4 H), 7.20–7.24 (m, 1 H), 5.22 (m, 1 H), 3.76–3.80 (m, 1 H), 3.29–3.35 (m, 2 H), 3.21–3.27 (m, 1 H), 2.39 (s, 3 H), 1.77–1.86 (m, 1 H), 1.51–1.60 (m, 1 H), 1.14–1.32 (m, 2 H). ¹³C NMR (100 MHz, CDCl₃): δ = 143.9, 140.6, 134.0, 129.9, 128.2, 127.7, 127.4, 126.2, 75.0, 66.1, 50.6, 25.7, 24.4, 21.6. IR (film): 3499, 3120, 2980, 1795, 1654, 1560, 1510, 1499, 1475, 1460, 930, 750 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for [C₁₈H₂₂NO₃S]⁺: 332.1315; found: 332.1333. [α]_D ^20.7 –156.4 (c = 0.042, MeOH).(R)-1-[(S)-1-Tosylpyrrolidin-2-yl]ethanol [(–)-15b)]: Colorless oil; R_f 0.40 (EtOAc–hexane, 20%). ¹H NMR (400 MHz, CDCl₃): δ = 7.68 (d, J = 8.12 Hz, 2 H), 7.29 (d, J = 8.01 Hz, 2 H), 4.15 (m, 1 H), 3.44–3.48 (m, 1 H), 3.27–3.37 (m, 2 H), 2.67 (br, 1 H), 2.39 (s, 3 H), 1.67–1.87 (m, 2 H), 1.50–1.62 (m, 1 H), 1.22–1.31 (m, 1 H), 1.12 (d, J = 6.45 Hz, 3 H). ¹³C NMR (100 MHz, CDCl₃): δ = 143.8, 134.1, 129.8, 127.6, 69.0, 65.8, 50.5, 26.1, 24.5, 21.5, 18.4. IR (film): 3503, 1654, 1561, 1402, 1331, 1159, 1059, 983, 662 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for [C₁₃H₂₀NO₃S]⁺: 270.1158; found: 270.1181. [α]_D ^22.2 –64.6 (c = 0.47, CH₂Cl₂).(R)-1-[(S)-1-Tosylpyrrolidin-2-yl]but-3-en-1-ol [(–)-15c)]: Colorless oil; R_f 0.43 (EtOAc–hexane, 20%). ¹H NMR (400 MHz, CDCl₃): δ = 7.67 (d, J = 8.23 Hz, 2 H), 7.29 (d, J = 8.0 Hz, 2 H), 5.80–5.90 (m, 1 H), 5.07–5.13 (m, 2 H), 4.05–4.09 (m, 1 H), 3.49–3.53 (m, 1 H), 3.26–3.38 (m, 2 H), 2.39 (s, 3 H), 2.14–2.26 (m, 2 H), 1.83–1.92 (m, 1 H), 1.70–1.77 (m, 1 H), 1.50–1.58 (m, 1 H), 1.22–1.31 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 143.7, 134.8, 134.1, 129.8, 127.7, 127.6, 117.4, 72.2, 64.4, 50.3, 37.8, 25.8, 24.6, 21.5. HRMS (ESI): m/z [M + H]⁺ calcd for [C₁₅H₂₂ NO₃S]⁺: 296.1315; found: 296.1336. [α]_D ^22.8 –90.3 (c = 0.43, CH₂Cl₂).(R)-1-[(S)-1-Tosylpyrrolidin-2-yl]prop-2-en-1-ol [(–)-15d)]: Colorless gel; R_f 0.49 (EtOAc–hexane, 20%). ¹H NMR (400 MHz, CDCl₃): δ = 7.69–7.71 (m, 2 H), 7.30 (d, J = 7.95 Hz, 2 H), 5.79–5.86 (m, 1 H), 5.30–5.36 (dt, J = 17.27, 1.58 Hz, 1 H), 5.17–5.21 (dt, J = 10.56, 1.55 Hz, 1 H), 4.46 (br, 1 H), 3.59–3.63 (m, 1 H), 3.26–3.39 (m, 2 H), 2.96 (d, J = 4.61 Hz, 1 H), 2.4 (s, 3 H), 1.70–1.83 (m, 2 H), 1.53–1.62 (m, 1 H), 1.22–1.30 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 143.9, 136.4, 134.0, 129.8, 127.6, 116.8, 74.5, 64.6, 50.6, 26.7, 24.5, 21.5; IR (film): 3584, 3099, 2981, 2059, 1870, 1655, 1544, 1474, 1154, 933 cm^–1. HRMS (ESI): m/z [M + H]⁺ calcd for [C₁₄H₁₉NO₃S]⁺: 282.1158; found: 282.1178. [α]_D ^27.0 –102.24 (c = 0.0352, MeOH).(R)-1-[(S)-1-Tosylpyrrolidin-2-yl]prop-2-yn-1-ol [(–)-15e)]: White crystalline solid; R_f 0.47 (EtOAc–hexane, 20%). ¹H NMR (500 MHz, CDCl₃): δ = 7.71 (d, J = 8.07 Hz, 2 H), 7.31 (d, J = 7.97 Hz, 2 H), 4.67 (br, 1 H), 3.67–3.70 (m, 1 H), 3.45–3.50 (m, 1 H), 3.42 (br s, 1 H), 3.29–3.34 (m, 1 H), 2.43 (d, J = 1.96 Hz, 1 H), 2.42 (s, 3 H), 1.96–2.0 (m, 1 H), 1.85–1.93 (m, 1 H), 1.73–1.80 (m, 1 H), 1.70 (m, 1 H). ¹³C NMR (100 MHz, CDCl₃): δ = 144.0, 133.9, 129.9, 127.6, 81.8, 74.4, 65.3, 64.3, 50.9, 27.9, 24.5, 21.6; IR (film): 3500, 3110, 2270, 1460, 1420, 1339, 1158, 1094 cm^–1. HRMS (ESI): m/z [M + Na]⁺ calcd for [C₁₄H₁₇NO₃S + Na]⁺: 302.0821; found: 302.0845. [α]_D ^20.7 –105 (c = 0.042, MeOH).

29a Tasso B, Novelli F, Sparatore F, Fasoli F, Gotti C. J. Nat. Prod. 2013; 76: 727
29b El-Naggar M, Piggott AM, Capon RJ. Org. Lett. 2008; 10: 4247
29c Vargas-Sanchez M, Couty F, Evano G, Prim D, Marrot J. Org. Lett. 2005; 7: 5861
29d Snider BB, Gao X. Org. Lett. 2005; 7: 4419
29e Roche C, Delair P, Greene AE. Org. Lett. 2003; 5: 1741

30a Pyrrolizidine alkaloids, see: Robertson J, Stevens K. Nat. Prod. Rep. 2014; 31: 1721 ; and references cited
30b For a review on indolizidine alkaloids, see: Michael JP. Nat. Prod. Rep. 2008; 25: 139 ; and references cited therein

31 For the use of N-tosyl-l-prolinal (10) in organic synthesis, see: Zhang Z, Wang F, Mu X, Chen P, Liu G. Angew. Chem. Int. Ed. 2013; 52: 7549

Zusatzmaterial

Supporting Information